Quick Answer
ARROWHEAD PHARMACEUTICALS, INC. reported Shares Outstanding of 135.70 million shares for fiscal year 2025.
ARROWHEAD PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 135.70M | +9.1% |
| 2024 | 124.38M | +15.9% |
| 2023 | 107.31M | +1.3% |
| 2022 | 105.96M | +1.6% |
| 2021 | 104.33M | +1.9% |
| 2020 | 102.38M | +7.2% |
| 2019 | 95.51M | +7.9% |
| 2018 | 88.51M | +18.3% |
| 2017 | 74.79M | +7.2% |
| 2016 | 69.75M | +17.1% |
| 2015 | 59.54M | +8.9% |
| 2014 | 54.66M | +68.2% |
| 2013 | 32.49M | +139.3% |
| 2012 | 13.58M | +57.1% |
| 2011 | 8.64M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 137.39M | +9.4% | +1.2% |
| September 30, 2025 | 135.70M | +9.1% | -1.8% |
| June 30, 2025 | 138.14M | +11.2% | +0.1% |
| March 31, 2025 | 138.06M | +11.2% | +9.9% |
| December 31, 2024 | 125.57M | +16.8% | +1.0% |
| September 30, 2024 | 124.38M | +15.9% | +0.1% |
| June 30, 2024 | 124.23M | +16.0% | +0.1% |
| March 31, 2024 | 124.13M | +16.2% | +15.5% |
- ARROWHEAD PHARMACEUTICALS, INC. showed an increase of +9.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, ARROWHEAD PHARMACEUTICALS, INC.’s shares outstanding has grown by 1470.2% (from 8.64 million shares to 135.70 million shares).
- The most recent figure is from ARROWHEAD PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: